Monika Fischer, MD, MSc, FACG

Indiana University

Poster(s):

• P2109 - Efficacy and Safety of Mirikizumab in Patients With Crohn’s Disease: 104-Week Extension Results From a Phase 2 Randomized Controlled Trial
  Monday, October 23, 2023

  10:30 AM – 4:15 PM PT